Support our Foundation of Myology project
1722 news items
The Danish experience with myasthenia gravis
On 25/08/2025
Danish researchers report the results of a large epidemiological study on mortality observed in myasthenia gravis between 1985 and 2020: the information was drawn from…
Gene therapy and DMD: a possible link with cardiac inflammation?
On 25/08/2025
Following the serious side effects observed during trials of micro–dystrophin gene therapy using an AAV viral vector in Duchenne muscular dystrophy (DMD), researchers at the…
DMD: Canakinumab reduces certain blood markers but not IL1b
On 14/08/2025
Canakinumab (Ilaris®) is a monoclonal antibody that neutralises interleukin 1 beta (IL1β), an inflammatory marker that is highly expressed in Duchenne muscular dystrophy. It is…
Advances in congenital muscular dystrophies – 2025
On 12/08/2025
This document presents a selection of congenital muscular dystrophy research news from these last 12 months: ongoing observational studies and clinical trials, scientific and medical…
The particularities of dermatomyositis on black skin
On 07/08/2025
The prevalence of dermatomyositis is higher in people with dark skin. After analysing 100 cases published since 1951, Canadian authors note that for this population:…
Advances in Charcot-Marie-Tooth disease – 2025
On 04/08/2025
This document presents a selection of congenital muscular dystrophy research news from these last 12 months: ongoing observational studies and clinical trials, scientific and medical…
Results of a trial of creatine monohydrate in a paediatric population with FSHD
On 04/08/2025
A randomised, double-blind, placebo-controlled trial was conducted in 13 children with facioscapulohumeral muscular dystrophy (FSHD) who received either creatine monohydrate or a placebo in a…
Diseases related to BAG3: a common variant associated with a more severe form
On 31/07/2025
This is the largest study conducted in Europe on the initiative of clinicians at the Institute of Myology, involving 26 patients with mutations in the…
The 2nd European Congress of CMT specialists will take place at the end of October in Belgium. Register now!
On 30/07/2025
Organised by the European Federation of CMT Associations, the University of Antwerp and the European CMT Research Association (ECRA), the second edition of this congress…
DMD: launch of the pivotal phase of Généthon’s gene therapy trial
On 30/07/2025
The results of the gene therapy trial (GNT0004) conducted by Généthon for Duchenne muscular dystrophy were presented on 17 May at the 2025 conference of…
An effective genomic editing approach in DMD
On 28/07/2025
In Duchenne muscular dystrophy (DMD), researchers used a CRISPR-Cas9 technique to correct the deletion of exon 52 of the DMD gene by targeting exon 53…
Prevalence of GNE myopathy probably underestimated
On 25/07/2025
GNE myopathy (GNEM) remains a particularly rare neuromuscular disease (with an estimated 1 to 9 cases per 1 million), probably because it remains poorly understood…
French experience of spinal surgery in patients with type II SMA
On 24/07/2025
Researchers at the Centre de Référence des maladies neuromusculaires at Trousseau Hospital in Paris have studied data from patients with SMN1 type II-related proximal spinal…
Lecture: Experimental models in research, advances and ethical issues
On 24/07/2025
REGISTRATION Free access, in person, upon prior registration (no video conferencing) As part of its reflections on Science, ethics and innovation in the field…
Genomic screening at birth: a revolution in the making
On 23/07/2025
Screening for rare diseases at birth using molecular biology is becoming a reality in several countries. The Screen4Care project brought together a group of experts…
Antibodies to MuSK CRD are pathogenic in a mouse model of myasthenia gravis
On 23/07/2025
Myasthenia gravis (MG) is caused by autoantibodies directed mainly against the acetylcholine receptor (AChR) or the MuSK receptor tyrosine kinase located at the neuromuscular junction.…
Inhibition of glutamate dehydrogenase as a new therapeutic approach in DMD
On 22/07/2025
European and Chinese researchers have focused on the glutamate pathway as a possible therapeutic target in Duchenne muscular dystrophy (DMD): this molecule plays an important…
MoCo MRF T1-FF: a new approach to accurately assess upper body muscle tissues using NMR despite respiratory motion
On 21/07/2025
Over the last decade, MR Fingerprinting (MRF) has emerged as an effective paradigm for the rapid and simultaneous quantification of several parameters using MRI. This…
Mapping dystrophin expression in the central nervous system
On 18/07/2025
In the context of the cognitive difficulties frequently observed in Duchenne muscular dystrophy (DMD), British researchers have reported work on the presence of dystrophin in…
Towards European standardisation of registers and digital tools for myasthenia gravis
On 18/07/2025
European experts met in conclave at the European Neuromuscular Center (ENMC) to define standards for the identification and management of patients with autoimmune myasthenia gravis.…
